206 related articles for article (PubMed ID: 7419008)
1. Abnormalities of vasoactive intestinal polypeptide-containing nerves in Crohn's disease.
Bishop AE; Polak JM; Bryant MG; Bloom SR; Hamilton S
Gastroenterology; 1980 Nov; 79(5 Pt 1):853-60. PubMed ID: 7419008
[TBL] [Abstract][Full Text] [Related]
2. Intestinal mucosa diamine oxidase activity reflects intestinal involvement in Crohn's disease.
Thompson JS; Burnett DA; Markin RS; Vaughan WP
Am J Gastroenterol; 1988 Jul; 83(7):756-60. PubMed ID: 3132852
[TBL] [Abstract][Full Text] [Related]
3. Microaggregate of immunostained macrophages in noninflamed gastroduodenal mucosa: a new useful histological marker for differentiating Crohn's colitis from ulcerative colitis.
Yao K; Yao T; Iwashita A; Matsui T; Kamachi S
Am J Gastroenterol; 2000 Aug; 95(8):1967-73. PubMed ID: 10950044
[TBL] [Abstract][Full Text] [Related]
4. Peptide-containing nerve fibres in the gut wall in Crohn's disease.
Sjölund K; Schaffalitzky OB; Muckadell DE; Fahrenkrug J; Håkanson R; Peterson BG; Sundler F
Gut; 1983 Aug; 24(8):724-33. PubMed ID: 6192043
[TBL] [Abstract][Full Text] [Related]
5. Immunocytochemical localization of vasoactive intestinal peptide and substance P in the colon from normal subjects and patients with inflammatory bowel disease.
Mazumdar S; Das KM
Am J Gastroenterol; 1992 Feb; 87(2):176-81. PubMed ID: 1370872
[TBL] [Abstract][Full Text] [Related]
6. Immunohistochemical localization of vascular endothelial growth factor in colonic mucosa of patients with inflammatory bowel disease.
Griga T; May B; Pfisterer O; Müller KM; Brasch F
Hepatogastroenterology; 2002; 49(43):116-23. PubMed ID: 11941933
[TBL] [Abstract][Full Text] [Related]
7. Altered inhibitory innervation of circular smooth muscle in Crohn's colitis. Association with decreased vasoactive intestinal polypeptide levels.
Koch TR; Carney JA; Go VL; Szurszewski JH
Gastroenterology; 1990 Jun; 98(6):1437-44. PubMed ID: 2338187
[TBL] [Abstract][Full Text] [Related]
8. Vasoactive intestinal peptide concentrations and immunocytochemical studies in rectal biopsies from patients with inflammatory bowel disease.
O'Morain C; Bishop AE; McGregor GP; Levi AJ; Bloom SR; Polak JM; Peters TJ
Gut; 1984 Jan; 25(1):57-61. PubMed ID: 6360814
[TBL] [Abstract][Full Text] [Related]
9. Peptidergic nerves in the colon of patients with ulcerative colitis.
Tomita R; Tanjoh K; Fujisaki S; Fukuzawa M
Hepatogastroenterology; 2000; 47(32):400-4. PubMed ID: 10791200
[TBL] [Abstract][Full Text] [Related]
10. Lack of vasoactive intestinal polypeptide nerves in esophageal achalasia.
Aggestrup S; Uddman R; Sundler F; Fahrenkrug J; Håkanson R; Sørensen HR; Hambraeus G
Gastroenterology; 1983 May; 84(5 Pt 1):924-7. PubMed ID: 6832568
[TBL] [Abstract][Full Text] [Related]
11. Colonic vasoactive intestinal polypeptide (VIP) in ulcerative colitis--a radioimmunoassay and immunohistochemical study.
Todorovic V; Janic B; Koko V; Micev M; Nikolic JA; Ratkovic M; Leposavic G; Jankovic T; Knezevic-Usaj S; Milicevic Z
Hepatogastroenterology; 1996; 43(9):483-8. PubMed ID: 8799381
[TBL] [Abstract][Full Text] [Related]
12. Substance P and vasoactive intestinal polypeptide but not calcitonin gene-related peptide concentrations are reduced in patients with moderate and severe ulcerative colitis.
Renzi D; Mantellini P; Calabrò A; Panerai C; Amorosi A; Paladini I; Salvadori G; Garcea MR; Surrenti C
Ital J Gastroenterol Hepatol; 1998 Feb; 30(1):62-70. PubMed ID: 9615269
[TBL] [Abstract][Full Text] [Related]
13. Vascular changes in ulcerative colitis and Leśniowski-Crohn's disease.
Zurawski J; Woźniak A; Salwa-Zurawska W; Kaczmarek E; Majewski P
Pol J Pathol; 2007; 58(1):13-21. PubMed ID: 17585538
[TBL] [Abstract][Full Text] [Related]
14. Increased production of vascular endothelial growth factor by intestinal mucosa of patients with inflammatory bowel disease.
Griga T; Voigt E; Gretzer B; Brasch F; May B
Hepatogastroenterology; 1999; 46(26):920-3. PubMed ID: 10370639
[TBL] [Abstract][Full Text] [Related]
15. Urinary excretion of N-methylhistamine as a marker of disease activity in inflammatory bowel disease.
Winterkamp S; Weidenhiller M; Otte P; Stolper J; Schwab D; Hahn EG; Raithel M
Am J Gastroenterol; 2002 Dec; 97(12):3071-7. PubMed ID: 12492192
[TBL] [Abstract][Full Text] [Related]
16. Different distribution of mast cells and macrophages in colonic mucosa of patients with collagenous colitis and inflammatory bowel disease.
Nishida Y; Murase K; Isomoto H; Furusu H; Mizuta Y; Riddell RH; Kohno S
Hepatogastroenterology; 2002; 49(45):678-82. PubMed ID: 12063968
[TBL] [Abstract][Full Text] [Related]
17. Real-time PCR quantification analysis of five mucosal transcripts in patients with Crohn's disease.
Eriksson A; Jennische E; Flach CF; Jorge A; Lange S
Eur J Gastroenterol Hepatol; 2008 Apr; 20(4):290-6. PubMed ID: 18334872
[TBL] [Abstract][Full Text] [Related]
18. Differential expression of vasoactive intestinal peptide receptor 1 expression in inflammatory bowel disease.
Yukawa T; Oshitani N; Yamagami H; Watanabe K; Higuchi K; Arakawa T
Int J Mol Med; 2007 Aug; 20(2):161-7. PubMed ID: 17611633
[TBL] [Abstract][Full Text] [Related]
19. Colon mucosa of patients both with spondyloarthritis and Crohn's disease is enriched with macrophages expressing the scavenger receptor CD163.
Demetter P; De Vos M; Van Huysse JA; Baeten D; Ferdinande L; Peeters H; Mielants H; Veys EM; De Keyser F; Cuvelier CA
Ann Rheum Dis; 2005 Feb; 64(2):321-4. PubMed ID: 15166002
[TBL] [Abstract][Full Text] [Related]
20. Axonal degeneration/necrosis: a possible ultrastructural marker for Crohn's disease.
Steinhoff MM; Kodner IJ; DeSchryver-Kecskemeti K
Mod Pathol; 1988 May; 1(3):182-7. PubMed ID: 3237698
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
